Anti-COLQ/ CMS5/ EAD monoclonal antibody

Anti-COLQ/ CMS5/ EAD antibody for FACS & in-vivo assay

Target products collectionGo to COLQ/COLQ products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0327-Ab-1/ GM-Tg-hg-MP0327-Ab-2Anti-Human COLQ monoclonal antibodyHuman
GM-Tg-rg-MP0327-Ab-1/ GM-Tg-rg-MP0327-Ab-2Anti-Rat COLQ monoclonal antibodyRat
GM-Tg-mg-MP0327-Ab-1/ GM-Tg-mg-MP0327-Ab-2Anti-Mouse COLQ monoclonal antibodyMouse
GM-Tg-cynog-MP0327-Ab-1/ GM-Tg-cynog-MP0327-Ab-2Anti-Cynomolgus/ Rhesus macaque COLQ monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0327-Ab-1/ GM-Tg-felg-MP0327-Ab-2Anti-Feline COLQ monoclonal antibodyFeline
GM-Tg-cang-MP0327-Ab-1/ GM-Tg-cang-MP0327-Ab-2Anti-Canine COLQ monoclonal antibodyCanine
GM-Tg-bovg-MP0327-Ab-1/ GM-Tg-bovg-MP0327-Ab-2Anti-Bovine COLQ monoclonal antibodyBovine
GM-Tg-equg-MP0327-Ab-1/ GM-Tg-equg-MP0327-Ab-2Anti-Equine COLQ monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0327-Ab-1/ GM-Tg-hg-MP0327-Ab-2; GM-Tg-rg-MP0327-Ab-1/ GM-Tg-rg-MP0327-Ab-2;
GM-Tg-mg-MP0327-Ab-1/ GM-Tg-mg-MP0327-Ab-2; GM-Tg-cynog-MP0327-Ab-1/ GM-Tg-cynog-MP0327-Ab-2;
GM-Tg-felg-MP0327-Ab-1/ GM-Tg-felg-MP0327-Ab-2; GM-Tg-cang-MP0327-Ab-1/ GM-Tg-cang-MP0327-Ab-2;
GM-Tg-bovg-MP0327-Ab-1/ GM-Tg-bovg-MP0327-Ab-2; GM-Tg-equg-MP0327-Ab-1/ GM-Tg-equg-MP0327-Ab-2
Products NameAnti-COLQ monoclonal antibody
Formatmab
Target NameCOLQ
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-COLQ benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species COLQ/ CMS5/ EAD VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP001477human COLQ Lentivirus particle
    ORF Viral VectorpGMLP001477human COLQ Lentivirus plasmid
    ORF Viral VectorpGMLPm005330mouse Colq Lentivirus plasmid
    ORF Viral VectorvGMLPm005330mouse Colq Lentivirus particle


    Target information

    Target IDGM-MP0327
    Target NameCOLQ
    Gene ID8292,382864,29755,694331,101093134,514615,100052475
    Gene Symbol and SynonymsA130034K24Rik,CMS5,COLQ,EAD
    Uniprot AccessionQ9Y215,O35167
    Uniprot Entry NameCOLQ_HUMAN,COLQ_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000206561
    Target ClassificationN/A

    The target: COLQ, gene name: COLQ, also named as CMS5, EAD. This gene encodes the subunit of a collagen-like molecule associated with acetylcholinesterase in skeletal muscle. Each molecule is composed of three identical subunits. Each subunit contains a proline-rich attachment domain (PRAD) that binds an acetylcholinesterase tetramer to anchor the catalytic subunit of the enzyme to the basal lamina. Mutations in this gene are associated with endplate acetylcholinesterase deficiency. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.